Welcure Drugs & Pharmaceuticals (BOM:524661) Common Stock: ₹1,236 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524661 Welcure Drugs & Pharmaceuticals Ltd BOM:524661
20 GF Score
Price ₹0.23
! 5 Warning Signs
View Full Analysis

What is Welcure Drugs & Pharmaceuticals Common Stock?

Welcure Drugs & Pharmaceuticals BOM:524661 20 Common Stock is ₹1,236 Mil as of Mar. 2026. GuruFocus rates BOM:524661 with a GF Score™ of 20/100. The stock has 5 warning signs investors should review.

Welcure Drugs & Pharmaceuticals's quarterly common stock declined from Sep. 2025 (₹1,124 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹1,236 Mil).

Welcure Drugs & Pharmaceuticals's annual common stock increased from Mar. 2024 (₹134 Mil) to Mar. 2025 (₹1,124 Mil) and increased from Mar. 2025 (₹1,124 Mil) to Mar. 2026 (₹1,236 Mil).

Welcure Drugs & Pharmaceuticals Common Stock Historical Data

* Premium members only.

The historical data trend for Welcure Drugs & Pharmaceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Welcure Drugs & Pharmaceuticals Common Stock Chart

Welcure Drugs & Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 121.19 134.39 134.39 1,124.39 1,235.94

Welcure Drugs & Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,124.39 0.00 1,124.39 0.00 1,235.94
BOM:524661
20GF Score
Welcure Drugs & Pharmaceuticals Ltd BOM:524661
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Welcure Drugs & Pharmaceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of ₹1,236 Mil mean?
Welcure Drugs & Pharmaceuticals (BOM:524661) has a Common Stock of ₹1,236 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Welcure Drugs & Pharmaceuticals and its competitors.
Is Welcure Drugs & Pharmaceuticals' Common Stock too high?
Welcure Drugs & Pharmaceuticals' current Common Stock is ₹1,236 Mil. Overall, Welcure Drugs & Pharmaceuticals has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Welcure Drugs & Pharmaceuticals' Common Stock compare to MCK and COR?
Welcure Drugs & Pharmaceuticals' Common Stock of ₹1,236 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Distribution company?
A good Common Stock depends on the Medical Distribution industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Welcure Drugs & Pharmaceuticals and its competitors. Welcure Drugs & Pharmaceuticals's current Common Stock is ₹1,236 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Welcure Drugs & Pharmaceuticals stock overvalued right now?
Welcure Drugs & Pharmaceuticals (BOM:524661) has a current Common Stock of ₹1,236 Mil. The current Common Stock is ₹1,236 Mil. Welcure Drugs & Pharmaceuticals' overall GF Score™ is 20/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Welcure Drugs & Pharmaceuticals (BOM:524661), the current Common Stock is ₹1,236 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Welcure Drugs & Pharmaceuticals Business Description

Address Laxmi Nagar, Plot No. 55, Office No. 104, First Floor, Vijay Block, Delhi East, Delhi, Delhi, IND, 110092
Welcure Drugs & Pharmaceuticals Ltd is a pharmaceutical company. The company operates exclusively in a single business segment: the trading of medical products. The company's revenue is entirely derived from this segment, encompassing a range of activities from sourcing pharmaceutical products to facilitating their distribution in domestic and international markets.
20GF Score

Get the complete analysis for BOM:524661

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹0.23
Price